Prehospital activated charcoal: the way forward

Area of Science:

• Emergency Medicine
• Toxicology
• Prehospital Care

Background:

• Single dose activated charcoal (SDAC) is a potential gastric decontamination method for drug overdose.
• Timely administration (within 1 hour) is crucial for SDAC efficacy, but few patients reach emergency departments within this window.
• Prehospital administration of SDAC could bridge this time gap.

Purpose of the Study:

• To assess UK ambulance NHS trusts' attitudes towards prehospital SDAC.
• To understand current practices, complications, and barriers to prehospital SDAC use.

Main Methods:

• A postal questionnaire survey was distributed to UK ambulance NHS trusts.
• The survey aimed to identify the current use of prehospital SDAC, associated complications, and barriers to its routine implementation.

Main Results:

• A 92% response rate was achieved with 36 out of 39 trusts participating.
• No responding trust currently offers prehospital SDAC.
• Key barriers include lack of evidence for efficacy, absence of a protocol, concerns about complications, and logistical issues.

Conclusions:

• The primary barrier to prehospital SDAC is the insufficient published evidence demonstrating its effectiveness in improving patient outcomes.
• Further research is essential to evaluate the utility and safety of SDAC in the prehospital setting.
• Development of recognized protocols is necessary for potential future implementation.